132 related articles for article (PubMed ID: 156065)
1. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine.
Houghton JA; Houghton PJ; Wooten RS
Cancer Res; 1979 Jul; 39(7 Pt 1):2406-13. PubMed ID: 156065
[No Abstract] [Full Text] [Related]
2. Identification and quantitation of 5-fluorouridine in rat urine after administration of 5-fluorouracil or 5-fluoro-2'-deoxyuridine.
Gelijkens CF; Sandra P; Belpaire F; De Leenheer AP
Drug Metab Dispos; 1980; 8(5):363-6. PubMed ID: 6107236
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
[TBL] [Abstract][Full Text] [Related]
4. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Klubes P; Cerna I
Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
[TBL] [Abstract][Full Text] [Related]
5. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
Chadwick M; Chang C
Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of thymidine after administration of fluorouracil and fluorouridine to adult and embryo mice.
Williams JP
Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):859-68. PubMed ID: 4264748
[No Abstract] [Full Text] [Related]
7. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
el Hag IA; Roos G; Jönsson PE; Stenram U
Anticancer Res; 1990; 10(1):29-32. PubMed ID: 2139770
[TBL] [Abstract][Full Text] [Related]
8. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
Ishiwata K; Ido T; Kawashima K; Murakami M; Takahashi T
Eur J Nucl Med; 1984; 9(4):185-9. PubMed ID: 6232143
[TBL] [Abstract][Full Text] [Related]
9. Effect of deoxyuridine coadministration on toxicity and antitumor activity of fluorouracil and floxuridine.
Jato JG; Lake LM; Grunden EE; Johnson BM
J Pharm Sci; 1975 Jun; 64(6):943-6. PubMed ID: 124347
[TBL] [Abstract][Full Text] [Related]
10. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
11. Glycosidic bond cleavage of 5-fluoro-2'-deoxyuridine and 5-fluorouridine by amino acyl-tRNA synthetases.
Kumar AM; Nayak R
Biochem Biophys Res Commun; 1990 Dec; 173(2):731-5. PubMed ID: 2148086
[TBL] [Abstract][Full Text] [Related]
12. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.
Pizzorno G; Wiegand RA; Lentz SK; Handschumacher RE
Cancer Res; 1992 Apr; 52(7):1660-5. PubMed ID: 1551097
[TBL] [Abstract][Full Text] [Related]
13. The embryotoxic effects of 5-fluoro-2'-deoxyuridine in mice.
Kleinbrecht J
Teratology; 1970 Nov; 3(4):315-8. PubMed ID: 4282423
[No Abstract] [Full Text] [Related]
14. Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice.
Harrison SD; Denine EP; Peckham JC
Cancer Treat Rep; 1978 Apr; 62(4):533-45. PubMed ID: 657150
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells.
Inaba M; Mitsuhashi J
Oncol Res; 1994; 6(7):303-9. PubMed ID: 7865905
[TBL] [Abstract][Full Text] [Related]
16. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
Houghton JA; Houghton PJ
Cancer; 1980 Mar; 45(5 Suppl):1159-67. PubMed ID: 6444543
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
Schuetz JD; Wallace HJ; Diasio RB
Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of cytotoxicity of 5-fluorouracil: distinction between the irreversible cytotoxic effect of 5-fluorouridine and the reversible cytotoxic effect of 5-fluoro-2'-deoxyuridine on murine lymphoma L5178Y cells in culture.
Kanzawa F; Hoshi A; Kuretani K
J Cancer Res Clin Oncol; 1980; 98(1):85-90. PubMed ID: 6450213
[TBL] [Abstract][Full Text] [Related]
19. Decreased immunosuppression associated with antitumor activity of 5-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine.
Connolly KM; Diasio RB; Armstrong RD; Kaplan AM
Cancer Res; 1983 Jun; 43(6):2529-35. PubMed ID: 6221793
[TBL] [Abstract][Full Text] [Related]
20. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
